The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...

A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival ...

Recommended Reading Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

British drugmaker GlaxoSmithKline sued Moderna in US federal court in Delaware on Tuesday (Oct 15), accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...

Key developments in the health sector include Abbott's profit boost from medical sales, the UK's assisted dying law debate, Donald Trump's reproductive remarks, BAT's synthetic nicotine launch, ...

Moderna is aware of the lawsuit and will defend itself against the claims, a spokesperson told Axios. Zoom out: GSK filed a ...